Corona

The major U.S. equity-indexes are hovering around all-time highs, and a question that frequently pops up these days,...

From a company barely known outside industry circles a year ago, Moderna (MRNA) has now become a household...

Coronavirus-focused stocks have been prone to surge majestically after the announcement of positive news. Last Friday, Applied DNA...

Inovio Pharmaceuticals’ (INO) 2020 was a tale of two contrasting halves. Shares skyrocketed during the first 6 months...

Arcturus Therapeutics (ARCT) investors felt the impact of a thunderous thud on Tuesday, following the share price’s collapse....

Returns wise, Novavax (NVAX) has undoubtedly been the most successful coronavirus stock of them all, with 2020 gains...

Last week, Moderna’s (MRNA) Covid-19 vaccine candidate mRNA-1273 became the second approved vaccine in the U.S. after it...

Hot on the heels of the FDA granting EUA (emergency use authorization) for Pfizer/BioNTech’s Covid-19 vaccine BNT162b2, last...

Last week, Moderna (MRNA) kicked off its TeenCOVE Study, dosing the first participants in the Phase 2/3 trial...

Covid-19 has been responsible for a complete shift in how society operates. On a lighter note, it has...

Moderna (MRNA) stock has been one of 2020’s star performers, up 695%, and judging by its real-world results,...

2020 has been some journey for Inovio Pharmaceuticals (INO). For this formerly little-known biotech, the narrative has swung...

Roche has partnered with Moderna Inc. to use its anti-SARS-CoV-2 S antibody test in mRNA-1273 vaccine research trials....

Pfizer Inc. and BioNTech’s mRNA vaccine candidate, BNT162b2, against COVID-19, was found to be safe and effective, according...

Eli Lilly & Co. and insurer UnitedHealth Group have teamed up to conduct a pragmatic study of the...

Shares of Moderna surged 10% on Thursday after it revealed subjects in the Phase 1 study led by...

Eli Lilly has struck an $812.5 million agreement with the US government to supply an additional 650,000 vials of...

Pfizer Inc. and its German partner BioNTech will start to supply the UK with their mRNA vaccine from...

Pfizer Inc. and its German partner BioNTech have filed a formal application to the European Medicines Agency (EMA)...

Shares of Novavax sank more than 9% in Monday’s pre-market session as the drugmaker further delayed the start...

Moderna announced that it will file for US and European emergency use of its COVID-19 vaccine candidate on...

Moderna has sealed a deal with the UK government for the supply of another 2 million doses of...

Moderna has inked a deal to supply European Union countries with up to 160 million doses of its...

Merck & Co has entered into a definitive agreement to snap up all of the outstanding shares of...

AstraZeneca said that its coronavirus vaccine candidate, which it is developing together with Oxford University, has shown an...

Regeneron announced that its REGN-COV2 investigational antibody cocktail therapy for the treatment of COVID-19, has been granted Emergency...

The US Food and Drug Administration (FDA) will review Pfizer Inc. and BioNTech’s request for emergency use authoriziation...

Pfizer plans to submit an application to the FDA for the emergency use of its COVID-19 vaccine today,...

Shares of Mesoblast gained 17% after it announced an exclusive worldwide license and collaboration agreement with Novartis for...

Eli Lilly and Incyte announced on Thursday that the FDA had granted Emergency Use Authorization (EUA) for the...

AstraZeneca’s coronavirus vaccine candidate, which it is developing together with Oxford University, induced a strong immune response in...

Pfizer Inc. and its German partner BioNTech are planning to apply for US emergency use authorization (EUA) for...

Germany’s CureVac announced that it will set up a European network to boost the manufacturing capacity of its...

Johnson & Johnson expects to have all the data needed to seek U.S. authorization for its experimental COVID-19...

Pfizer Inc has kicked off a pilot delivery program for its COVID-19 vaccine candidate in four US states,...

BioNTech and Shanghai partner Fosun Pharma have been granted regulatory approval to commence the clinical trial for their...

Shares of Inovio Pharmaceuticals jumped 11% after the US Food & Drug Administration (FDA) cleared the way for...

Shares of Moderna spiked 15% in Monday’s pre-market session as the company disclosed that its vaccine candidate, mRNA-1273,...

Johnson & Johnson said that it has kicked off a Phase 3 clinical trial in the UK to...

Shares of Qiagen rose as much as 4% in Wednesday’s extended market session after the medical diagnostics company...

Moderna said it has collated sufficient data for the first interim analysis of the Phase 3 study of...

Pfizer (PFE) and BioNTech SE have won a contract to supply European Union (EU) Member States with 300 million...

Shares of Eli Lilly & Co. rose as much as 5% in Tuesday’s pre-market session after the US...

Humanigen (HGEN) has announced positive interim Phase 3 data of lenzilumab in patients hospitalized with COVID-19. Shares are now...

AstraZeneca will present late-stage trial data for its Covid-19 vaccine candidate later this year as the UK drugmaker...

Hologic saw its quarterly earnings more than triple bolstered by strong demand for its COVID-19 tests, sending shares...

Novavax (NVAX) has signed a non-binding heads of terms document with the Australian Government to supply 40 million...

Humanigen (HGEN) has announced the execution of its first licensing transaction in the Asia-Pacific Region with Telcon RF Pharmaceutical, Inc....

Shares in TFF Pharmaceuticals closed 6.5% higher on Monday as the clinical-stage biopharma company announced that it has...

Johnson & Johnson has struck a preliminary agreement with Aspen Pharmacare Holdings to manufacture its Covid-19 vaccine candidate...